Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • January
  • Page 138
machine-learning-unveils-bacillus-anthracis-adaptability-and-virulence
Posted inBiotechnology

Machine Learning Unveils Bacillus anthracis Adaptability and Virulence

January 7, 2026
In a groundbreaking study, researchers have delved deep into the genetic secrets of one of the world’s most infamous pathogens,…
Read More
ai-predicts-trauma-deaths-real-time-across-nations
Posted inBiotechnology

AI Predicts Trauma Deaths Real-Time Across Nations

January 7, 2026
In an era where artificial intelligence continues to reshape the landscape of medicine, a groundbreaking study has emerged that promises…
Read More
genetic-insights-boost-catalpa-huangxin-conservation-efforts
Posted inBiotechnology

Genetic Insights Boost Catalpa huangxin Conservation Efforts

January 7, 2026
In the face of accelerating climate change and human encroachment, the future of many plant species teeters on the brink…
Read More
servier-sharpens-its-focus-on-rare-neurology
Posted inBiotechnology

Servier Sharpens Its Focus on Rare Neurology

January 7, 2026
Rare neurology is entering a pivotal moment. Scientific understanding is accelerating, new technologies are maturing, and the patient need remains…
Read More
essential-cancer-screening:-what-science-recommends
Posted inBiotechnology

Essential Cancer Screening: What Science Recommends

January 7, 2026
Cancer screening stands at a pivotal juncture in its history, poised for revolutionary transformation due to recent technological advancements in…
Read More
pulmocide-calls-curtains-on-phase-3-antifungal-trial-over-low-response,-higher-mortality-rate
Posted inBiotechnology

Pulmocide calls curtains on phase 3 antifungal trial over low response, higher mortality rate

January 7, 2026
The show is over for Pulmocide’s phase 3 trial after patients who received its investigational inhaled antifungal had lower response…
Read More
ai-optimizes-dance-movements-for-aesthetics-and-biomechanics
Posted inBiotechnology

AI Optimizes Dance Movements for Aesthetics and Biomechanics

January 7, 2026
In a groundbreaking new study, researchers have unveiled a deep learning framework designed to optimize dance movements both aesthetically and…
Read More
glp-1-agonists:-broad-clinical-outcomes-reviewed
Posted inBiotechnology

GLP-1 Agonists: Broad Clinical Outcomes Reviewed

January 7, 2026
In a groundbreaking synthesis of clinical data, a recent umbrella review spearheaded by Kong, Zhao, Zhang, and colleagues critically assesses…
Read More
human-led-truck-platooning-enhances-efficient-logistics
Posted inBiotechnology

Human-Led Truck Platooning Enhances Efficient Logistics

January 7, 2026
The future of logistics is on the brink of a seismic shift, driven by innovative advances in autonomous vehicle technology…
Read More
amgen-dances-with-disco-in-$618m-cancer-target-pact
Posted inBiotechnology

Amgen dances with Disco in $618M cancer target pact

January 7, 2026
Amgen is getting down with Disco Pharmaceuticals, commissioning the German outfit to work on cancer therapies focused on a target…
Read More

Posts pagination

Previous page 1 … 136 137 138 139 140 … 171 Next page

Privacy Policy    Terms

Scroll to Top